This retrospective cohort study included 7,938 adult patients with obesity or overweight in Ohio and Florida
New medications are just one way we tackle cardiovascular disease
Flow Wellness recommends contacting your provider if: Symptoms continue to worsen Redness persists for several days Significant swelling develops The area becomes painful or warm You suspect an allergic reaction You have concerns about your medication Early evaluation can help identify the cause and prevent unnecessary discomfort
Currently, the most popular GLP1-based monotherapy, Semaglutide, controls blood sugar by promoting insulin secretion and induces a lasting sense of fullness to reduce appetite
They may be able to switch you to a covered GLP1 for a different indication (e.g., prescribing Ozempic for diabetes instead of Wegovy for weight loss) or help you appeal a denial
Available: [2] Press release: New Pediatric Obesity Clinical Practice Guideline | Obesity Canada. Accessed: Nov